Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
IMFINZI® (durvalumab) regimen reduced the risk of disease recurrence or death by 32% in high-risk non-muscle-invasive bladder cancer in the POTOMAC Phase III trial
-
IMUNON Invited to Present PlaCCine® DNA Technology Proof-of-Concept Data in Platform Presentations at Leading Vaccine Conferences
-
Kalma Capital Corp. Announces Resignation of Director
-
Proven Strength, New Chapters Ahead: Chery Super Hybrid (CSH) Global Endurance Test Concludes in Triumph, Paving the Way for the 2025 Chery Brand User Summit
-
Bybit x Block Scholes Quarterly Report: Rise of Perp DEXs -- and How to Catch the Opportunity
-
Savara Announces Chief Medical Officer (CMO) Transition
-
Butterfly Network to Report Third Quarter 2025 Financial Results on October 31, 2025
-
Home Trends & Design Announces Strategic Alliance with FurnitureDealer.net
-
Samsung Electronics Completes Acquisition of Xealth, Accelerating Connected Care
-
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Heidrick & Struggles International, Inc. (Nasdaq - HSII), Comerica Incorporated (NYSE - CMA), Veeco Instruments
-
ClearNote Health to Showcase Latest Advancements in Early Cancer Detection Testing at ESMO Congress 2025
-
Iconic Announces Equity Financing up to $2,550,000
-
Sphere 3D Announces a Warrant Inducement Transaction for $4.0 Million in Gross Proceeds
-
Agios’ PYRUKYND® (mitapivat) Receives Positive CHMP Opinion for Adults with Thalassemia
-
Alta and Poshmark Announce Partnership to Bring AI Shopping and Virtual Try-On to Secondhand and Vintage Fashion Enthusiasts
-
Family-Owned Danish Brand Sees Explosive U.S. Growth - Without Outside Investors
-
Perimeter Medical Imaging AI to Participate in the Planet MicroCap Showcase in Toronto
-
Leidos and VML debut Imperium™, new AI-powered platform to enhance U.S. strategic information operations
-
Vertiv to Participate in Upcoming Investor Conference
-
Visteon Declares Quarterly Dividend of $0.275 Per Share
-
Manitoba Farmers: Safely Dispose of Unwanted Pesticides and Old Livestock/Equine Medications This October
-
DeFi Technologies to Attend the 2025 Maxim Growth Summit
-
Paramount to Report Third Quarter 2025 Financial Results on November 10, 2025
-
PIRELLI: CYBER TYRE AWARDED AS THE MOST INNOVATIVE TIRE TECHNOLOGY AT THE AUTOTECH BREAKTHROUGH AWARDS 2025
-
Hingham Public Schools to Break Ground on New Electric School Bus Project
-
Rental affordability reaches four-year high
-
Volition Donates Nu.Q® Vet Cancer Tests to HOPE Animal-Assisted Crisis Response Dogs
-
Lilly's Verzenio® (abemaciclib) prolonged survival in HR+, HER2-, high-risk early breast cancer with two years of treatment
-
Total Energy Services Inc. Plans To Repurchase Shares
-
ID.me and Flexpa Partner to Give Patients Trusted Access to Their Health Data, Fight AI-Driven Fraud, and Advance Healthcare Interoperability
-
BANCFIRST CORPORATION REPORTS THIRD QUARTER EARNINGS
-
Marengo Presents Initial Phase 2 Results Demonstrating Broad Single-Agent Activity of Invikafusp Alfa Across Multiple PD-1-Refractory or -Resistant Solid Tumors as a Late-Breaking Oral Presentation at
-
MAX Power Selects Premier Drilling Contractor for Canada’s First Dedicated Natural Hydrogen Well
-
Apnimed To Present Additional Phase 3 Data for AD109, an Investigational Oral Pill for Obstructive Sleep Apnea, at CHEST 2025 Annual Meeting
-
Anthem Blue Cross and Blue Shield and Sauk Prairie Healthcare to Strengthen Health Outcomes in Wisconsin
-
Terex Announces Third Quarter 2025 Financial Results Conference Call
-
Delivering on Voters' Priority for Higher Education and Training Could Add $20 Billion to Arizona's Economy
-
Dogness Reports Financial Results for Fiscal Year Ended June 30, 2025
-
Sensei Biotherapeutics Reports New Clinical Results Highlighting Durable Progression Free Survival Data for Solnerstotug in PD-(L)1 Resistant Tumors at the ESMO Congress 2025
-
Changes to Index Tracked by Sprott Uranium Miners ETF (URNM)
-
Newegg Business Partners with Credit Key to Provide Flexible Financing Options, with Extended-Term Options Up to 12 Months
-
IMFINZI® (durvalumab)-based regimen reduced the risk of death by 22% in early gastric cancer vs. chemotherapy alone in MATTERHORN Phase III trial
-
Franklin Templeton Closed-End Funds Announce Share Repurchases for the Third Quarter of 2025
-
SRx Health Solutions Received NYSE American Notification Letter Regarding Stockholders' Equity Deficiency
-
Vor Bio Announces Late-Breaking Oral Presentation of China Phase 3 IgA Nephropathy Clinical Study at American Society of Nephrology’s Kidney Week 2025
-
Alliant Energy Corporation declares quarterly common stock dividend
-
29% of U.S. Home Purchases Are Made in Cash, Essentially Flat From a Year Ago
-
Republic Bancorp Reports a 12% Increase in Third Quarter Net Income
-
Actress Kate Hudson Brings Bold Personality and Glamour to Her Kitchen Remodel with CAFÉ™
-
Treasure Data Achieves the AWS Generative AI Competency
